Clinical Trials List
2010-04-01 - 2013-12-31
Phase III
Study ended7
ICD-10I25.10
Atherosclerotic heart disease of native coronary artery without angina pectoris
ICD-9429.2
Cardiovascular disease, unspecified
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- 顏學偉 Division of Cardiovascular Diseases
- 鄭凱鴻 Division of Cardiovascular Diseases
- 溫文才 Division of Cardiovascular Diseases
- 朱志生 Division of Cardiovascular Diseases
- Ye-Hsu Lu Division of Cardiovascular Diseases
- 李碩粲 Division of Cardiovascular Diseases
- Tsung-Hsien Lin Division of Cardiovascular Diseases
- Po-Chao Hsu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Tao-Cheng Wu Division of Cardiovascular Diseases
- Po-Hsun Huang Division of Cardiovascular Diseases
- Tse-Min Lu Division of Cardiovascular Diseases
- Shih-Hsien Sung Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- 吳文憲 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
200 participants
-
Global
13000 participants
